Conversely, higher GLP1R expression correlated with worse survival in cervical squamous cell carcinoma (HR = 2.17, logrank p = 0.0074), head-neck squamous cell carcinoma (HR = 1.57, logrank p = 0.0063), lung squamous cell carcinoma (HR = 1.47, logrank p = 0.0098), stomach adenocarcinoma (HR = 1.31, logrank p = 0.026), colon carcinoma (HR = 1.35, logrank p = 0.0032), and uterine corpus endometrial carcinoma (HR = 2.36, ogrank p < 0.0001). Here, GLP1R is linked to uterine corpus endometrial carcinoma.